November 03, 2023
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Back to Healio
Patients with asthma who were hospitalized for COVID-19 had less severe disease and lower mortality rates than patients with no airway disease, according to a study published in The Journal of Allergy or Clinical Immunology: In Practice.
However, patients with COPD who were hospitalized for COVID-19 had more severe disease and higher mortality rates than those with no airway disease, Yunqing Liu, MS, PhD, department of biostatistics, Yale School of Public Health, and colleagues wrote.
The study examined data from 8,395 patients admitted to Yale New Haven Health System between March 1, 2020, and April 1, 2021, for COVID-19. These patients included 969 with asthma, 1,132 with COPD, 768 with both asthma and COPD and 5,526 with no airway disease.
The 11.5% prevalence of asthma in this population was comparable with the 10.5% prevalence of asthma throughout Connecticut, the researchers said. COPD prevalence included 13.5% in the study cohort and 6.1% in the state, indicating increased risk for hospitalization for COVID-19 for patients with COPD, the researchers continued.
Patients with no airway disease had a median sequential organ failure assessment (SOFA) score of 0.32. Comparatively, patients with asthma had a significantly lower median SOFA score, at 0.15 (P < .01), and the patients with COPD had a significantly higher median score, at 0.86 (P < .01).
Compared with the absolute mortality rate of 11% among those with no airway disease, patients with asthma showed a significantly lower rate at 5%, whereas those with COPD showed a significantly higher rate at 21% (P < .01 for both). However, at 14%, the absolute mortality rate among those with asthma and COPD did not significantly differ from the no airway disease group, suggesting that asthma and COPD may have offsetting effects on the severity of COVID-19, the researchers wrote.
Specifically, compared with the no airway disease group, a multivariate logistic regression analysis showed patients with asthma had 35% lower adjusted odds for mortality of COVID-19 (OR = 0.65; 95% CI, 0.48-0.89) whereas patients with COPD had 40% higher odds for mortality (OR = 1.4; 95% CI, 1.16-1.67).
Patients with no airway disease and those with both asthma and COPD had comparable odds for mortality (OR = 0.99; 95% CI, 0.77-1.26), further suggesting that asthma may offset the risk for severe COVID-19 among patients with COPD, the researchers wrote.
Further, the researchers found significant associations between mortality and higher total white blood cell counts, immature granulocyte counts and neutrophil counts in all four disease groups.
Elevated blood eosinophil counts, which the researchers noted are biomarkers of T2 inflammation, were associated with lower risks for mortality in all four disease groups, especially for patients with asthma. Also, patients with asthma, including those with both asthma and COPD, had higher levels of eosinophils on admission.
Specifically, after adjusting for cofounders, patients with absolute eosinophil counts of 200 cells/L or higher had lower odds for mortality compared with patients with lower eosinophil counts (OR = 0.52; 95% CI, 0.33-0.8).
But after adjusting for eosinophil levels, these differences in mortality between the groups persisted, including an odds ratio of 0.67 (95% CI, 0.49-0.92) for the asthma group and 1.38 (95% CI, 1.15-1.66) for COPD, indicating that peripheral eosinophilia does not fully explain the protection associated with asthma, according to the researchers.
Noting significant differences in exposure to systemic corticosteroids between the groups, the researchers also found an overall increase in mortality associated with IV methylprednisolone therapy (OR = 4.77; 95% CI, 3.69-6.17), which they called expected due to its selective use in patients with severe COVID-19.
Yet multiple regression analysis adjusted for exposure to systemic corticosteroids still showed a significant increase in mortality among patients with COPD and a significant decrease in patients with asthma and eosinophilia.
Patients at risk for severe COVID-19 require more intensive mitigation strategies such as social distancing, vaccine boosters and early outpatient pharmacotherapy, the researchers wrote, making their identification critical.
Based on these results, patients with COPD are at higher risk for severe COVID-19 and patients with asthma are at lower risk, the researchers continued. These differences may be due to protection conferred by T2 inflammation, the researchers added, but further clinical and mechanistic studies would be needed to confirm this association.
Collapse
Liu Y, et al. J Allergy Clin Immunol Pract. 2023;doi:10.1016/j.jaip.2023.07.006.
Disclosures: Liu reports no relevant financial disclosures. Please see the study for all other authors relevant financial disclosures.
Denisa E. Ferastraoaru, MD
One of the most interesting findings is that differences in mortality between patients with asthma and COPD persisted even after adjustment for serum eosinophil counts. This suggests that peripheral eosinophilia might not be the main nor the only factor associated with lower mortality of COVID-19 in patients with asthma.
This might explain why patients with asthma on biologics working on the T2 pathway do not have worse COVID-19 outcomes than those not on monoclonal biologics. Likewise, COPD worsened outcomes even among those with high eosinophil counts. This demonstrates fundamental differences between asthma and COPD.
The results that COVID-19 patients with higher absolute eosinophil counts (greater than 200 cells/L) had lower odds of mortality compared with those with lower serum eosinophil levels are similar with our prior published data in our Bronx asthmatic population.
Since the beginning of the pandemic, we noticed that our patients with asthma do better in terms of COVID-19 outcomes compared with those who do not have asthma. Even now, 3 years after the COVID-19 pandemic started, we cannot fully explain these observations. However, clinical and mechanistic research studies have emerged since that hopefully will shed more light in this field.
It is possible that the differences in lung inflammation in those with pre-existing asthma and pre-existing COPD are important in COVID-19 outcomes, as well as the age and associated comorbidities. It is known that COPD patients are older, a factor that is associated by itself with worse COVID-19 outcomes.
Although at this time there are no differences in the way we treat COVID-19 patients with asthma and COPD, current findings suggest that COVID-19 prevention strategies and early outpatient treatment for SARS-CoV-2 infection should be implemented with priority for patients with COPD.
Although there is overlap in the medications used to treat these chronic respiratory conditions, this is a clear demonstration of how these two differ. Characterizing respiratory disease accurately as asthma or COPD is important to risk assess patients and to provide them anticipatory guidance.
The exact mechanism through which patients with asthma have lower odds for dying of COVID-19 is not clear. More data are also needed to identify if the odds for mortality of COVID-19 vary based on other allergic disorders, such as allergic rhinitis, rhinosinusitis and atopic dermatitis. Identifying these mechanisms might develop into new treatment and preventative modalities.
It is important to extend this observation to other respiratory viral infections. Does eosinophilia help prevent other viral asthma or COPD exacerbations? We need to understand if eosinophils are the cells that help fight or prevent serious COVID-19 infections. Alternatively, they could be markers of a milieu that is unfavorable to COVID-19. Understanding how the eosinophilic state reduces COVID-19 morbidity and mortality is an important next step.
Manish Ramesh, MD, PhD, associate professor and chief of the division of allergy-immunology, Albert Einstein College of Medicine/Montefiore Medical Center, also contributed to this Perspective.
Reference:
Ferastraoaru DE, et al. J Allergy Clin Immunol Pract. 2021;doi:10.1016/j.jaip/2020.12.045.
Denisa E. Ferastraoaru, MD
Associate Professor, Allergy-Immunology, Albert Einstein College of Medicine/Montefiore Medical Center
Disclosures: Ferastraoaru reports no relevant financial disclosures.
Add topic to email alerts
Receive an email when new articles are posted on
Back to Healio
Original post:
Asthma associated with lower mortality among patients hospitalized ... - Healio
- Biohackers Are on a Secret Hunt for the Coronavirus Vaccine - Reason [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Can synthetic biology protect us from coronavirus? And the next one? - Big Think [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- When will there be a coronavirus vaccine and who will get it first? - Yahoo News [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- These nine companies are working on coronavirus treatments or vaccines heres where things stand - MarketWatch [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus Vaccine At Least a Year Away, But Treatment Could Be Here in Months - Newsweek [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus Drug and Vaccine Studies Are Recruiting Their First Volunteers - TIME [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Brexit means coronavirus vaccine will be slower to reach the UK - The Guardian [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- First patient injected in trial of coronavirus vaccine - WCVB Boston [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- A coronavirus vaccine is in the making But you may have to check your pockets first - Duke Chronicle [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus vaccines and treatment: Everything you need to know - CNET [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus outbreak: How much testing should we do, and where are we on developing a vaccine? - Economic Times [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Coronavirus Vaccines Precision Vaccinations [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- How Long Will It Take to Develop a Vaccine for Coronavirus? [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- California lab says it discovered coronavirus vaccine in 3 hours [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Coronavirus outbreak in Wuhan, China: Vaccine may be ready in ... [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Everything You Need to Know About Canine Coronavirus Vaccine [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- CSU Researchers Are Working Full-Bore On The Mysteries Of Coronavirus And A Vaccine - Colorado Public Radio [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- How soon will we have a coronavirus vaccine? The race against covid-19 - New Scientist [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Coronavirus trial vaccine participant says he wants to help the world - CNN [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Daily briefing: The five questions that scientists hunting a coronavirus vaccine must answer - Nature.com [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Baltimore scientists to work on third experimental coronavirus vaccine - Baltimore Sun [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- The coronavirus could kill millions of Americans: 'Do the math,' immunization specialist says - CNBC [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- We're still in the early days of coronavirus vaccine research - Axios [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Inoculating the Coronavirus Vaccine Against the Profit Pandemic - The New Republic [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Wanted: People Willing to Get Sick to Find Coronavirus Vaccine - The Wall Street Journal [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Coronavirus vaccine trial, Mars rover delay and a boost for UK science - Nature.com [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Thousands of scientists are racing to find a vaccine for coronavirus. 41 possibilities are in the works. - The Californian [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- 'I Wanted To Do Something,' Says Mother Of 2 Who Is First To Test Coronavirus Vaccine - NPR [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Vaccine Trials To Fight Coronavirus Offer Hope, Could Be Harbinger Of New Technology - Outlook India [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Image of COVID-19 test kit shared as newly developed 'coronavirus vaccine' by Roche - Alt News [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- A coronavirus vaccine is the only thing that can make life 'perfectly normal' again, former FDA commissioner says - The Week [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Johnson & Johnson CEO on potential coronavirus vaccine: 'I think we'll have important data by the end of the year' - Fox News [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- As the First Coronavirus Vaccine Human Trials Begin, Manufacturer Is Already Preparing to Scale Production to Millions - TIME [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- A coronavirus vaccine is the only thing that can make life 'perfectly normal' again, former FDA commissioner says - Yahoo News [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- This Vaccine Could Save Health Care Workers From the Coronavirus - Foreign Policy [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Coronavirus vaccine must be affordable and accessible - The Conversation CA [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Over 100 drugs are in testing in the race to treat coronavirus - Axios [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- This is when the first coronavirus drugs might actually be available - BGR [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Another Day, Another Meme to Debunk: Vaccines for the Bovine Coronavirus Will Not Cure COVID-19 - Mother Jones [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- A Coronavirus Vaccine Could Be the First That Outwits Nature - Singularity Hub [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Coronavirus treatment other than vaccines may be available soon - The Jerusalem Post [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Coronavirus: Vaccine hopes given boost as researcher says virus not mutating - The Independent [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Coronavirus Vaccine Is Critical, The Infection Could Become Seasonal, Researchers Warn - NDTV News [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- A coronavirus vaccine from Virginia? These researchers are working on it. - The Virginian-Pilot - The Virginian-Pilot [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Scientists, under pressure, try to balance speed and safety on coronavirus vaccine research - NBCNews.com [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Should scientists infect healthy people with the coronavirus to test vaccines? - Nature.com [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Coronavirus Vaccines May Not Work for the Elderlyand This Lab Aims to Change That - Scientific American [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Vaccine Development Is Risky Business. Biotechs Are Tackling The Coronavirus, Anyway - WBUR [Last Updated On: March 29th, 2020] [Originally Added On: March 29th, 2020]
- Coronavirus vaccine: how soon will we have one? - World Economic Forum [Last Updated On: March 29th, 2020] [Originally Added On: March 29th, 2020]
- USC Working on Coronavirus Vaccine, Researchers Announce - NBC Southern California [Last Updated On: March 29th, 2020] [Originally Added On: March 29th, 2020]
- Tracking the development of coronavirus treatments - NBC News [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- In the fight against coronavirus, antivirals are as important as a vaccine. Here's where the science is up to - The Conversation AU [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- Johnson & Johnson Says It Could Have Coronavirus Vaccine Ready by Early 2021 - The Daily Beast [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- Coronavirus: when will the vaccine be ready? - AS South Africa [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- A Coronavirus Vaccine Is Coming, And It Will Work - City Journal [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- With record-setting speed, vaccinemakers take their first shots at the new coronavirus - Science Magazine [Last Updated On: April 1st, 2020] [Originally Added On: April 1st, 2020]
- CDC: Coronavirus Vaccine Will Be Ready for Refusal By Anti-Vaxxers By 2021 - MedPage Today [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- The race to find a coronavirus treatment has one major obstacle: big pharma - The Guardian [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- Why A Coronavirus Vaccine May Be Years Away - The National Interest [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- The race is on for coronavirus vaccines and treatments: current R&D status - The Pharma Letter [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- Tests of potential coronavirus vaccine spur growth of virus-fighting antibodies - USA TODAY [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- A 100-yr-old vaccine is being tested against the new coronavirus. Can it work? - Economic Times [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- Coronavirus Live Updates: Boris Johnson Moved to Intensive Care and the U.S. Death Toll Surpasses 10,000 - The New York Times [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- When will a coronavirus shot be ready? A look at the vaccine race. - WRAL.com [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- Hulk Hogan on coronavirus: Maybe we dont need a vaccine - Tampa Bay Times [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- White House advisor Fauci says coronavirus vaccine trial is on target and will be 'ultimate game changer' - CNBC [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- Coronavirus vaccine will take time, so researchers are hunting for and finding promising new COVID-19 tre - OregonLive [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- Chester County to begin testing for coronavirus antibodies; British prime minister moved to intensive care - The Philadelphia Inquirer [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- MAP: Where coronavirus treatments and vaccines are being tested on patients in the US - Business Insider - Business Insider [Last Updated On: April 6th, 2020] [Originally Added On: April 6th, 2020]
- Coronavirus pandemic: Why it takes so long to make a vaccine - Business Today [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- A vaccine for coronavirus is the goal, but what does it take to get there? - ABC News [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- Trump says there's light at the end of the tunnel with coronavirus vaccine and treatment research - CNBC [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- Russia Ready to Start Testing Coronavirus Vaccines on Humans in June - The Moscow Times [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- Why a coronavirus vaccine takes over a year to produce and why that is incredibly fast - World Economic Forum [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- Pandemic expert calls for manufacturing coronavirus vaccines before they're proven to work - The Week [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- More Coronavirus Vaccine Efforts Move Toward Human Trials - The New York Times [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- A coronavirus vaccine is being developed in record time. But don't expect that technology to speed up flu vaccines yet. - USA TODAY [Last Updated On: April 8th, 2020] [Originally Added On: April 8th, 2020]
- A New Front for Nationalism: The Global Battle Against a Virus - The New York Times [Last Updated On: April 10th, 2020] [Originally Added On: April 10th, 2020]
- Here's how your body gains immunity to coronavirus - The Guardian [Last Updated On: April 10th, 2020] [Originally Added On: April 10th, 2020]
- Pfizer aims to create coronavirus vaccine by end of 2020 - MLive.com [Last Updated On: April 10th, 2020] [Originally Added On: April 10th, 2020]